Free Access
Issue
Med Sci (Paris)
Volume 30, Number 8-9, Août–Septembre 2014
Page(s) 730 - 732
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20143008005
Published online 01 September 2014
  1. De Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005 ; 19 : 2100–2110. [CrossRef] [PubMed] [Google Scholar]
  2. Neidle S. Parkinson GN. The structure of telomeric DNA. Curr Op Struct Biol 2003 ; 13 : 275–283. [CrossRef] [Google Scholar]
  3. Benetti R. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 2007 ; 39 : 243–250. [CrossRef] [PubMed] [Google Scholar]
  4. Tang J. Histone deacetylases as targets for treatment of multiple diseases. Clin Sci 2013 ; 124 : 651–662. [CrossRef] [PubMed] [Google Scholar]
  5. Palacios JA. SIRT1 contributes to telomere maintenance and augments global homologous recombination. J Cell Biol 2010 ; 191 : 1299–1313. [CrossRef] [PubMed] [Google Scholar]
  6. Michishita E. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008 ; 452 : 492–496. [CrossRef] [PubMed] [Google Scholar]
  7. Michishita E. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 2009 ; 8 : 2664–2666. [CrossRef] [PubMed] [Google Scholar]
  8. Woo HJ. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. Exp Mol Pathol 2007 ; 82 : 77–84. [CrossRef] [PubMed] [Google Scholar]
  9. Peixoto P. HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells. Cell Death Diff 2012 ; 19 : 1239–1252. [CrossRef] [Google Scholar]
  10. Uziel O. Telomere shortening sensitizes cancer cells to selected cytotoxic agents: In vitro and in vivo studies and putative mechanisms. Plos One 2010 ; 5 : 1–14. [CrossRef] [PubMed] [Google Scholar]
  11. Arturo Londoño-Vallejo J. Un Nobel centenaire célèbre télomères et télomérase. Med Sci (Paris) 2009 ; 25 : 973–976. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Touzot F, Le Guen T, de Villartray JP, Révy P. Nouvelles formes de dyskératoses congénitales. Med Sci (Paris) 2012 ; 28 : 618–624. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.